MIRM FY 2025 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$521M+54.7% YoY

Gross Profit

$421M80.7% margin

Operating Income

-$22M-4.2% margin

Net Income

-$23M-4.5% margin

EPS (Diluted)

$-0.47

Cash Flow

Operating Cash Flow

$56M

Free Cash Flow

$55M

Stock-Based Comp.

$71M

Balance Sheet

Total Assets

$843M

Total Liabilities

$528M

Stockholders' Equity

$315M

Cash & Equivalents

$297M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$521M	$337M	+54.7%
Gross Profit	$421M	$255M	+64.8%
Operating Income	-$22M	-$88M	+74.7%
Net Income	-$23M	-$88M	+73.4%